Cercar
01/01/2023
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Jr, ARO, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. ADVANCES IN THERAPY. 2023; 40(2)DOI:10.1007/s12325-022-02360-6. PMID:36502449. IF:3.400(Q2/3D).
01/01/2023
Quality of life in pituitary diseases
Webb S.M., Valassi E.. Quality of life in pituitary diseases. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.03.001. PMID:. IF:(Q/D).
01/12/2022
Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases
Webb, SM, Kristensen, J, Nordenstrom, A, Vitali, D, Amodru, V, Wiehe, LK, Bolz-Johnson, M. Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases. Endocrine Connections. 2022; 11(12)DOI:10.1530/EC-22-0385. PMID:36228311. IF:2.900(Q3/8D).
01/10/2022
Quality of life impairment after a diagnosis of Cushing's syndrome
Webb, SM, Valassi, E. Quality of life impairment after a diagnosis of Cushing's syndrome. Pituitary. 2022; 25(5)DOI:10.1007/s11102-022-01245-9. PMID:35767164. IF:3.800(Q2/5D).